Matúš Vojtek
@matus_vojtek
Postdoctoral researcher @IMPvienna interested in transcriptional regulation.
ID: 909404574070530048
17-09-2017 13:12:01
129 Tweet
188 Followers
274 Following
#Viruses play a role in approx. 10 % of human #cancers. Scientists from labs of Anna Obenauf (IMP) & Thomas Wiesner (MedUni Wien) now show that human papillomavirus 42 (HPV42) drives development of certain #skincancer. Published in Cancer Discovery: doi.org/10.1158/2159-8…
📜 Happy to share our recent preprint featuring ORFtag - a versatile, easy and cost-effective method for probing protein function at a proteome scale. This work is the result of a collaborative effort by the StarkLab, Stefan L Ameres, Ulrich Elling and @juliusbrennecke labs. 1/2
🎉Congratulations to Filip Nemcko from Alexander Stark's lab for being included in Forbes Slovakia “30 Under 30” list! To earn him the mention is the development of a method that significantly speeds up the understanding of human gene functions. imp.ac.at/news/article/f…
So happy to share our new pre-print, which illuminates how SHH+ floor plate cells contribute to spinal cord regeneration in axolotls. biorxiv.org/content/10.110… I couldn't be more proud of lead author Laura Arb and dream partners Emanuel Cura Costa, Osvaldo Chara and Elly Tanaka! 1/14
ORFtag enables protein functional screens by proteome-wide tagging via randomly integrated cassettes. Filip Nemcko Ulrich Elling @juliusbrennecke Alexander Stark StarkLab IMBA imbavienna.bsky.social IMP Max Perutz Labs Vienna Vienna BioCenter nature.com/articles/s4159…
Our preprint "Predictive design of tissue-specific mammalian enhancers that function in vivo in the mouse embryo" is on bioRxiv: biorxiv.org/content/10.648… . Amazing collaboration by Shenzhi Chen, Loubiere (IMP, Vienna BioCenter), ... (1/2)
Now on bioRxiv: Activator-promoter compatibility in mammals - Hcfc1 is a key and intrinsically CGI-promoter-specific co-activator that cannot activate non-CGI promoters. Lead by Filip Nemcko & Kevin Sabath in collab. with Plaschka Lab (IMP) biorxiv.org/content/10.648… (1/2)